Form 4: VICOR CORP: Insider Sells Shares Under 10b5-1 Plan

James F. Schmidt, CFO and Director of VICOR CORP, reported the sale of 1,000 shares of common stock for $100 each, executed under a pre-arranged Rule 10b5-1 trading plan.

Summary

• James F. Schmidt, who holds the positions of CFO, Treasurer, Secretary, Director, and is a 10% owner of VICOR CORP, has reported a transaction involving common stock.
• On June 25, 2026, Mr. Schmidt acquired 1,000 shares of common stock at a price of $100 per share.
• Concurrently, on the same date, Mr. Schmidt disposed of a total of 1,000 shares of common stock through multiple transactions.
• These sales occurred at a weighted average price, with individual sales ranging from $326.72 to $342.51 per share.
• The transactions were conducted under a Rule 10b5-1 trading plan adopted by Mr. Schmidt on December 10, 2025, which is designed to satisfy affirmative defense conditions for insider trading.
• Following these transactions, Mr. Schmidt's beneficial ownership of common stock has been adjusted.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While insider selling can be a negative signal, the execution under a Rule 10b5-1 plan mitigates concerns about opportunistic trading, and the acquisition at a lower price suggests a planned exercise of options.

Positives

• The sale was executed under a Rule 10b5-1 trading plan, indicating a pre-determined and structured approach to stock disposition, which can mitigate concerns about insider trading.
• The acquisition of 1,000 shares at $100 per share suggests a potential investment or exercise of options at a specific price point.

Negatives

• A significant number of shares (1,000) were sold by a key executive and director, which could be perceived negatively by the market.
• The sale of shares at prices significantly higher than the acquisition price ($326.72 - $342.51 vs. $100) indicates a substantial profit-taking by the insider.

Risks

• While executed under a 10b5-1 plan, significant insider selling can sometimes be interpreted as a lack of confidence in future stock performance, potentially impacting investor sentiment.
• The specific details of the Rule 10b5-1 plan, such as its duration and the rationale for its adoption, are not fully elaborated in this filing, leaving room for speculation.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. The only future-oriented information pertains to the vesting and expiration of stock options and the ongoing nature of the Rule 10b5-1 plan.

Management Comments

• The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
• The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $326.7200 to $327.4600.
• The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $328.2700 to $329.2000.
• The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.6800 to $330.6400.
• The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.7800 to $331.0700.
• The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $331.840 to $331.8400.
• The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.0500 to $333.9000.
• The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.5100 to $335.2000.
• The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.0900 to $338.0900.
• The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.5100 to $342.5100.
• Granted under the Companys Amended and Restated 2000 Stock Option and Incentive Plan on June 25, 2021 and vest over a five year period.

Industry Context

StockSavvy.ai notes that Form 4 filings detailing insider transactions are common for publicly traded companies. The use of a Rule 10b5-1 plan by a senior executive like a CFO is a standard practice to diversify holdings or manage personal finances while adhering to insider trading regulations. The significant price difference between the acquisition and sale of shares suggests the reporting person may have exercised stock options granted under an incentive plan.

Stakeholder Impact

• Shareholders: May interpret the sale of shares by a key executive as a potential signal, although the Rule 10b5-1 plan provides a degree of reassurance against negative insider trading perceptions.
• Employees: May observe the transaction as part of the company's executive compensation and stock incentive programs.
• Management: The transaction reflects the execution of personal financial planning and compliance with regulatory requirements by a senior executive.

Next Steps

• The reporting person's stock options granted on June 25, 2021, will continue to vest over a five-year period.
• The Rule 10b5-1 trading plan adopted on December 10, 2025, will continue to govern future transactions as per its terms.

Key Dates

Keywords

SEC Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Beneficial Ownership, VICOR CORP, VICR, James F. Schmidt, CFO, Director, Stock Options